Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

NCT07124117 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120

NCT00715403 ·Status: COMPLETED ·Phase: PHASE1

BIBX 1382 in Treating Patients With Solid Tumors

NCT00003980 ·Status: SUSPENDED ·Phase: PHASE1

Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors

NCT00730821 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171663 ·Status: COMPLETED ·Phase: PHASE1

BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171650 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

NCT04138823 ·Status: COMPLETED ·Phase: PHASE1

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated

NCT05327946 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

NCT02171702 ·Status: COMPLETED ·Phase: PHASE1

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

NCT02483247 ·Status: COMPLETED ·Phase: PHASE1

A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors

NCT02432326 ·Status: COMPLETED ·Phase: PHASE1

An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours

NCT02182206 ·Status: COMPLETED ·Phase: PHASE1

A Study of QBI-139 in Subjects With Advanced Solid Tumors

NCT00818831 ·Status: UNKNOWN ·Phase: PHASE1

A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

NCT04147247 ·Status: COMPLETED ·Phase: PHASE1

This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)

NCT03604445 ·Status: TERMINATED ·Phase: PHASE1

This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)

NCT03449381 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757 ·Status: COMPLETED ·Phase: PHASE1

Monotherapy Dose Finding With BI 847325 in Solid Tumours

NCT01324830 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

NCT02952248 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

NCT03166631 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

NCT06480240 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit

NCT02211872 ·Status: COMPLETED ·Phase: PHASE1

A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies

NCT01325441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors

NCT00869388 ·Status: COMPLETED ·Phase: PHASE1

BI 811283 in Various Solid Tumours

NCT00701324 ·Status: COMPLETED ·Phase: PHASE1